Management of Prameha (Type 2 Diabetes Mellitus) with Ayurveda Formulations as Adjuvant Therapy: A Case Report
Introduction: Prameha, described in Āyurveda as a tridoṣaja and medo-pradoṣaja disorder, shares close clinical correlation with Type 2 Diabetes Mellitus (T2DM). It is characterized by polyuria or turbid urine (prabhūta/avila mūtra) and is associated with unhealthy dietary habits (apathya-sevana), sedentary lifestyle, and hereditary predisposition (sahaja hetu). Case Information: A 37-year-old woman with a 10-year history of T2DM was receiving conventional therapy comprising high-dose insulin (54 units/day) and oral hypoglycemic agents. Despite ongoing treatment, she had persistent polyuria (bahu-mūtratā), weakness (daurbalya), and burning sensation in the feet (pāda-dāha). Intervention: An integrative regimen comprising Paṭolakaturohiṇyādi kaṣāya tablets, Triphala guggulu, and Madhumeharī cūrṇa was prescribed alongside dietary and lifestyle modifications, while conventional therapy was continued initially and tapered gradually. Results: Over five months, HbA1c reduced from 8.5% to 6.1%, fasting blood glucose normalized, symptoms resolved, and insulin was discontinued. Oral hypoglycemic doses were also reduced. Conclusion: This case demonstrates the potential of Āyurvedic formulations as adjuvant therapy in the integrative management of T2DM, enabling reduction of pharmacological dependence and improvement in quality of life. Keywords: Prameha, Āyurveda, Type 2 Diabetes Mellitus, Madhumeharī cūrṇa, Triphalā guggulu, Paṭolakaturohiṇyādi kaṣāya
Authors
- Shailza Bhatnagar (ORCID: https://orcid.org/0000-0003-2566-1107)
- Kalpana Yadav (ORCID: https://orcid.org/0000-0003-4540-9419)
- Deepak Jangid
- Ambika Hegde
Institutions
- National Institute of Ayurveda (IN)
Publication Details
- Journal
- International Journal of Ayurveda360
- Published
- 2025-10-14
- DOI
- https://doi.org/10.63247/3048-7390.vol.2.issue2.4
- Primary Topic
- Phytochemicals and Medicinal Plants
- Type
- article
- Field-Weighted Citation Impact
- 0.00